Home NDC 10147-0686 methylphenidate Hydrochloride
Product NDC 10147-0686
11-digit product format 101470686
Labeler code 10147
Product ID 10147-0686_5e2dbcde-b6a2-11ec-9a3d-d90cfed203d4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name methylphenidate hydrochloride
Dosage form TABLET
Route ORAL
Labeler Patriot Pharmaceuticals, LLC.
Application NDA021121
Marketing category NDA
Marketing start 2000-08-01
Marketing end 0000-00-00
Substance METHYLPHENIDATE HYDROCHLORIDE
Active strength 36 mg/1
Pharmacologic classes Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE]
DEA schedule CII
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 1 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 10147-0686 10147-0686-1 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 4 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N021121-001 CONCERTA METHYLPHENIDATE HYDROCHLORIDE 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 N021121-002 CONCERTA METHYLPHENIDATE HYDROCHLORIDE 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 N021121-003 CONCERTA METHYLPHENIDATE HYDROCHLORIDE 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 N021121-004 CONCERTA METHYLPHENIDATE HYDROCHLORIDE 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 4 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 5 · 180 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 c2088c7a36db…2026-09-14 22:38:34 2026-08 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021121-001 CONCERTA 18MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021121-002 CONCERTA 36MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2000-08-01 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021121-003 CONCERTA 54MG TABLET, EXTENDED RELEASE / ORAL AB RLD, RS 2000-12-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N021121-004 CONCERTA 27MG TABLET, EXTENDED RELEASE / ORAL AB RLD 2002-04-01 03ed91905a0d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 5 · 180 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 10147-0686 METHYLPHENIDATE HYDROCHLORIDE TABLET [PATRIOT PHARMACEUTICALS, LLC.] 10 Legacy NDC 20231130_dad446b7-b26c-44f2-9e30-4cbd10d8b23c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join CONCERTA METHYLPHENIDATE HYDROCHLORIDE Janssen Pharmaceuticals, Inc. 1a88218c-5b18-4220-8f56-526de1a276cd 2026-04-20 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 021121 application number: NDA021121
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 10147-0686-1 10147068601 100 TABLET in 1 BOTTLE (10147-0686-1) 100 tablet 2019-02-18 0000-00-00 No No Current